These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 15813744

  • 1. Regulation of azole drug susceptibility by Candida albicans protein kinase CK2.
    Bruno VM, Mitchell AP.
    Mol Microbiol; 2005 Apr; 56(2):559-73. PubMed ID: 15813744
    [Abstract] [Full Text] [Related]

  • 2. RTA2, a novel gene involved in azole resistance in Candida albicans.
    Jia XM, Ma ZP, Jia Y, Gao PH, Zhang JD, Wang Y, Xu YG, Wang L, Cao YY, Cao YB, Zhang LX, Jiang YY.
    Biochem Biophys Res Commun; 2008 Sep 05; 373(4):631-6. PubMed ID: 18601908
    [Abstract] [Full Text] [Related]

  • 3. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
    Ricardo E, Costa-de-Oliveira S, Dias AS, Guerra J, Rodrigues AG, Pina-Vaz C.
    FEMS Yeast Res; 2009 Jun 05; 9(4):618-25. PubMed ID: 19416368
    [Abstract] [Full Text] [Related]

  • 4. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
    Vermitsky JP, Earhart KD, Smith WL, Homayouni R, Edlind TD, Rogers PD.
    Mol Microbiol; 2006 Aug 05; 61(3):704-22. PubMed ID: 16803598
    [Abstract] [Full Text] [Related]

  • 5. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
    Walsh TJ, Kasai M, Francesconi A, Landsman D, Chanock SJ.
    J Med Vet Mycol; 1997 Aug 05; 35(2):133-7. PubMed ID: 9147273
    [Abstract] [Full Text] [Related]

  • 6. CRZ1, a target of the calcineurin pathway in Candida albicans.
    Karababa M, Valentino E, Pardini G, Coste AT, Bille J, Sanglard D.
    Mol Microbiol; 2006 Mar 05; 59(5):1429-51. PubMed ID: 16468987
    [Abstract] [Full Text] [Related]

  • 7. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
    Niimi M, Niimi K, Takano Y, Holmes AR, Fischer FJ, Uehara Y, Cannon RD.
    J Antimicrob Chemother; 2004 Dec 05; 54(6):999-1006. PubMed ID: 15486081
    [Abstract] [Full Text] [Related]

  • 8. Drug resistance genes and trailing growth in Candida albicans isolates.
    Lee MK, Williams LE, Warnock DW, Arthington-Skaggs BA.
    J Antimicrob Chemother; 2004 Feb 05; 53(2):217-24. PubMed ID: 14688046
    [Abstract] [Full Text] [Related]

  • 9. Mutations in the CgPDR1 and CgERG11 genes in azole-resistant Candida glabrata clinical isolates from Slovakia.
    Berila N, Borecka S, Dzugasova V, Bojnansky J, Subik J.
    Int J Antimicrob Agents; 2009 Jun 05; 33(6):574-8. PubMed ID: 19196495
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J.
    Antimicrob Agents Chemother; 1995 Nov 05; 39(11):2378-86. PubMed ID: 8585712
    [Abstract] [Full Text] [Related]

  • 11. Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis.
    Cernicka J, Subik J.
    Int J Antimicrob Agents; 2006 May 05; 27(5):403-8. PubMed ID: 16621465
    [Abstract] [Full Text] [Related]

  • 12. Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients.
    Looi CY, D' Silva EC, Seow HF, Rosli R, Ng KP, Chong PP.
    FEMS Microbiol Lett; 2005 Aug 15; 249(2):283-9. PubMed ID: 16006060
    [Abstract] [Full Text] [Related]

  • 13. Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection.
    Pancholi P, Park S, Perlin D, Kubin C, Della-Latta P.
    J Clin Microbiol; 2004 Dec 15; 42(12):5938-9. PubMed ID: 15583347
    [Abstract] [Full Text] [Related]

  • 14. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
    Pourakbari B, Teymuri M, Mahmoudi S, Valian SK, Movahedi Z, Eshaghi H, Mamishi S.
    Infect Disord Drug Targets; 2017 Dec 15; 17(3):178-184. PubMed ID: 28558643
    [Abstract] [Full Text] [Related]

  • 15. Serum repressing efflux pump CDR1 in Candida albicans.
    Yang YL, Lin YH, Tsao MY, Chen CG, Shih HI, Fan JC, Wang JS, Lo HJ.
    BMC Mol Biol; 2006 Jul 13; 7():22. PubMed ID: 16839415
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans.
    Chen CG, Yang YL, Tseng KY, Shih HI, Liou CH, Lin CC, Lo HJ.
    Fungal Genet Biol; 2009 Sep 13; 46(9):714-20. PubMed ID: 19527793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.